Buprenorphine Personnel
Report abuse
Sign up for free
Name
Site
HFHS
Count3
1
Joslyn Westphal
2
Shilling Zhang
3
Brian Ahmedani
4
Monique Does
5
Sujaya Parthasarathy
6
Cynthia Campbell
7
Alison Truman
8
Deborah Ling-Grant
9
Joanna Barreras
10
Rulin Hechter
11
Adam Hernandez
12
Melissa Bautista
13
Gregory Simon
14
Charissa Tomlinson
15
Rebecca Ziebell
Site
KPNC
Count4
Site
KPSC
Count5
Site
KPWA
Count3
Drag to adjust the number of frozen columns
Pronouns
MHRN Role
Title
Email
Photo
Background/Education
Mental/behavioral health related research interests
Currently lives:
What I do for fun
Projects
Interest groups
Site
Project Manager
jwestph1@hfhs.org
An Evaluation of the National Zero Suicide Model Across Learning Healthcare Systems (ZS)
Impact and Implications of Rapid Transition to Virtual Mental Health Care during COVID-19 (COVID Supplement)
Buprenorphine Effect on Suicidal Behavior
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
Mental Health Research Network III Administrative Core
Development of a population-based risk calculator for suicidal behavior (SRS3)
MHRN VDW
HFHS
Programmer/Analyst
szhang3@hfhs.org
Buprenorphine Effect on Suicidal Behavior
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
HFHS
Investigator/Researcher
Site PI
Senior Scientist / Director
bahmeda1@hfhs.org

Brian Ahmedani, PhD, LMSW, is a mental health services researcher with primary interests in suicide prevention.

Impact and Implications of Rapid Transition to Virtual Mental Health Care during COVID-19 (COVID Supplement)
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
An Evaluation of the National Zero Suicide Model Across Learning Healthcare Systems (ZS)
Buprenorphine Effect on Suicidal Behavior
Mental Health Research Network III Administrative Core
Development of a population-based risk calculator for suicidal behavior (SRS3)
Child & Adolescent Mental Health SIG
Comorbidities SIG
Equity Research SIG
MHRN VDW
Suicide Prevention SIG
HFHS
Project Manager
Research Project Manager
Monique.Does@kp.org
Buprenorphine Effect on Suicidal Behavior
KPNC
Programmer/Analyst
Senior Data Consultant/Health Economist
Sujaya.Parthasarathy@kp.org

PhD Econometrics from University of Southern CaliforniaUtilization, Cost, cost-effectiveness and cost-offset analyses of studies involving patients (adults and adolescents) with sub-stance use and or mental health disorders.

 I work on studies that examine health care utilization, cost, cost-effectiveness and cost-offset analyses of studies involving patients (adults and adolescents) with substance use and or mental health disorders.

Oakland, CA
Buprenorphine Effect on Suicidal Behavior
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
An Evaluation of the National Zero Suicide Model Across Learning Healthcare Systems (ZS)
KPNC
Investigator/Researcher
Research Scientist III
Cynthia.I.Campbell@kp.org
Buprenorphine Effect on Suicidal Behavior
KPNC
Grants Management
Senior Research Administrator
Alison.Truman@kp.org
Buprenorphine Effect on Suicidal Behavior
KPNC
Project Manager
Lead Senior Research Project Manager
Deborah.S.Ling-Grant@kp.org
Buprenorphine Effect on Suicidal Behavior
MHRN VDW
KPSC
Project Manager
Joanna.L.Barreras@kp.org
Buprenorphine Effect on Suicidal Behavior
KPSC
Investigator/Researcher
Research Investigator I, MD
Rulin.C.Hechter@kp.org
Buprenorphine Effect on Suicidal Behavior
KPSC
Grants Management
Research Business Administrator III
Adam.X.Hernandez@kp.org
Buprenorphine Effect on Suicidal Behavior
KPSC
Grants Management
melissa.v.bautista@kp.org
Buprenorphine Effect on Suicidal Behavior
KPSC
Site PI
Physician Investigator
Gregory.E.Simon@kp.org
An Evaluation of the National Zero Suicide Model Across Learning Healthcare Systems (ZS)
Buprenorphine Effect on Suicidal Behavior
Mental Health Research Network III Methods Core
Using NLP to increase identification of child maltreatment in EHR
Impact and Implications of Rapid Transition to Virtual Mental Health Care during COVID-19 (COVID Supplement)
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
PHQ9 differential item functioning
Stakeholder Perspectives on Implementing Suicide Risk Prediction Models (PP1)
Outreach to Reduce Disparities in Depression Treatment Initiation (PP2)
Digital Mindfulness Based Cognitive Therapy for Perinatal Depression (Mindful Mood Balance for Moms, SP1)
Mental Health Research Network III Administrative Core
Development of a population-based risk calculator for suicidal behavior (SRS3)
KPWHRI Behavioral Health SIG
Child & Adolescent Mental Health SIG
Comorbidities SIG
Equity Research SIG
Methods SIG
MHRN VDW
Perinatal Mental Health SIG
KPWHRI Biostat/IT & Suicide Risk Prediction
KPWA
She/Her/Hers
Project Manager
Research Project Manager
Charissa.m.Tomlinson@kp.org
Issaquah, Wa
Effects of Medical Products on Suicidal Ideation and Behavior - Real World Evidence (FDA)
Mental Health Research Network III Administrative Core
An Evaluation of the National Zero Suicide Model Across Learning Healthcare Systems (ZS)
Impact and Implications of Rapid Transition to Virtual Mental Health Care during COVID-19 (COVID Supplement)
Buprenorphine Effect on Suicidal Behavior
Mental Health Research Network III Methods Core
MHRN VDW
KPWHRI Biostat/IT & Suicide Risk Prediction
KPWA
Programmer/Analyst
Programmer
Rebecca.A.Ziebell@kp.org
Buprenorphine Effect on Suicidal Behavior
MHRN VDW
KPWHRI Biostat/IT & Suicide Risk Prediction
KPWA
15 records

Alert

Lorem ipsum
Okay